Literature DB >> 17545773

Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.

Silvio Danese1.   

Abstract

PURPOSE OF REVIEW: Inflammatory bowel disease pathogenesis involves the interplay of multiple biological factors, among which nonimmune cells, including the endothelium, represent a crucial component of disease pathogenesis. RECENT
FINDINGS: Endothelial cells play a key role in chronic inflammation through multiple and disparate activities. The mucosal microvasculature in inflammatory bowel disease is dysfunctional, overexpresses inflammatory molecules and undergoes intense angiogenesis, failing to exert its physiological antiinflammatory and anticoagulant activities.
SUMMARY: The mucosal microcirculation is abnormal in inflammatory bowel disease and represents a novel component of disease pathogenesis; targeting the various abnormalities of the inflammatory bowel disease microcirculation may lead to new forms of therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545773     DOI: 10.1097/MOG.0b013e32810c8de3

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  18 in total

Review 1.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

2.  Protein kinase C iota in the intestinal epithelium protects against dextran sodium sulfate-induced colitis.

Authors:  Shelly R Calcagno; Shuhua Li; Muhammad W Shahid; Michael B Wallace; Michael Leitges; Alan P Fields; Nicole R Murray
Journal:  Inflamm Bowel Dis       Date:  2010-11-15       Impact factor: 5.325

3.  Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in Endoglin heterozygous mice.

Authors:  Mirjana Jerkic; Madonna Peter; Daniela Ardelean; Michael Fine; Moritz A Konerding; Michelle Letarte
Journal:  Inflamm Bowel Dis       Date:  2010-11       Impact factor: 5.325

Review 4.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 5.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

6.  Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.

Authors:  Anja Schirbel; Nancy Rebert; Tammy Sadler; Gail West; Florian Rieder; Christoph Wagener; Andrea Horst; Andreas Sturm; Carol de la Motte; Claudio Fiocchi
Journal:  Inflamm Bowel Dis       Date:  2019-01-10       Impact factor: 5.325

7.  Cellular and molecular mechanisms of intestinal fibrosis.

Authors:  Silvia Speca; Ilaria Giusti; Florian Rieder; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

8.  NKX2-3 transcriptional regulation of endothelin-1 and VEGF signaling in human intestinal microvascular endothelial cells.

Authors:  Wei Yu; John P Hegarty; Arthur Berg; Xi Chen; Gail West; Ashley A Kelly; Yunhua Wang; Lisa S Poritz; Walter A Koltun; Zhenwu Lin
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  Thrombospondin-1 and VEGF in inflammatory bowel disease.

Authors:  Canan Alkim; Damlanur Sakiz; Huseyin Alkim; Ayten Livaoglu; Tulin Kendir; Huseyin Demirsoy; Levent Erdem; Nihat Akbayir; Mehmet Sokmen
Journal:  Libyan J Med       Date:  2012-01-30       Impact factor: 1.657

10.  Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis.

Authors:  Munkhtugs Davaatseren; Jin-Taek Hwang; Jae Ho Park; Myung-Sunny Kim; Shuaiyu Wang; Mi Jeong Sung
Journal:  Mediators Inflamm       Date:  2013-05-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.